to study the Effect of Gokshursiddha ghrit will be check in assymetrical intrauterine growth retarded fetus in pregnant woman.

The study of the effectiveness of Gokshursiddha ghrit in vatabhippana shushka garbha with special reference to assymetrical IUGR INTRAUTERINE GROWTH RESTRICTION - Nil

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2026/02/103227

Enrollment

120

Registered

2026-02-06

Start date

Unknown

Completion date

Unknown

Last updated

2026-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O998- Other specified diseases and conditions complicating pregnancy, childbirth and the puerperium

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Voluntary participants ANC patients with GA 28-30 weeks Singleton pregnancy Mild asyymetrical IUGR with normal AFI Primipara as well as multipara Age between 20-35 years With normal anomaly scan report

Exclusion criteria

Exclusion criteria: Medical & surgical illness complicating pregnancy such as anaemia, heart disease, TB, glycosuria, thyroid dysfunction, jaundice, STD, pyelo-nephritis, epilepsy, viral infection, asthma, hypertension disorders (Pre- eclampsia, eclampsia) , chronic renal disease, infections etc Multiton pregnancies

Design outcomes

Primary

Measure	Time frame
Adequate fetal growthTimepoint: Baseline - after 2, 4, 6 weeks	—

Secondary

Measure	Time frame
To study the number of patients having IUGR in relation to parity. To study the disease according to etiological factors. To study the effect of Gokshur on apara (placenta ).,garbh, garbhini. To study the drug Gokshur & its properties (Brihan) from Ayurvedic literatures To reduce peri-natal morbidity & mortality due to Vatabhipanna shushka garbha To study the clinical diagnosis of IUGR, ultrasound findings of IUGR To study the association between IUGR & nature of delivery Timepoint: Baseline - after 2 , 4 , 6 weeks	—

Measure

Time frame

To study the number of patients having IUGR in relation to parity. To study the disease according to etiological factors. To study the effect of Gokshur on apara (placenta ).,garbh, garbhini. To study the drug Gokshur & its properties (Brihan) from Ayurvedic literatures To reduce peri-natal morbidity & mortality due to Vatabhipanna shushka garbha To study the clinical diagnosis of IUGR, ultrasound findings of IUGR To study the association between IUGR & nature of delivery Timepoint: Baseline - after 2 , 4 , 6 weeks

—

Countries

India

Contacts

Public ContactDr Trupri Jaideep Kale

Y.M.T.Ayurvedic Medical College,And Hospital , P.G.Institute , Kharghar , Navi Mumbai , 10

seema.mehre@gmail.com9930940403

Outcome results